Lara Sullivan has more than two decades of experience and senior leadership in biopharmaceuticals, healthcare and life sciences, most recently at Pfizer. While at Pfizer she helmed strategy and portfolio operations for the company’s early stage pipeline and led the work, inside Pfizer and with outside patient groups and partners, to create SpringWorks Therapeutics. Lara joined Pfizer from McKinsey & Company, where she was an associate partner in the pharmaceutical and medical products practice advising biopharmaceutical clients on a variety of strategic and operational issues, with a particular emphasis on R&D productivity. Additionally, Lara was a principal at Paul Capital Partners leading due diligence for investments in the healthcare fund, and earlier in her career worked in healthcare equity research and municipal finance at CS First Boston. Lara holds an MD from the University of Pennsylvania School of Medicine, an MBA from The Wharton School at the University of Pennsylvania, and a BA in comparative literature from Cornell University.